GPT Healthcare has provided its operational and financial guidance for FY27, projecting a 15% year-over-year increase in revenue and an EBITDA margin expansion to approximately 20.2%. The guidance was shared during the earnings conference call for the quarter and year ended March 31, 2026.

Financial Outlook for FY27

The company anticipates EBITDA margin growth of around 100 basis points. This expansion is expected to be driven by improved occupancy levels, higher patient throughput, and a stronger specialty mix across mature hospitals. The Average Revenue Per Occupied Bed (ARPOB) is projected to grow by approximately 8%, supported by tariff increases and specialty optimization.

Unit-Level Occupancy Targets

Management has set specific occupancy targets for its key hospital units for the fiscal year. The focus remains on improving bed utilization across the network.

Raipur Hospital and Jamshedpur Expansion

The newly commissioned Raipur Hospital is projected to reach monthly operational breakeven by Q3 FY27, closing the fiscal year at around 30% occupancy. The facility is expected to record a slight full-year loss before turning fully positive in the subsequent year.

GPT Healthcare also expects to commission the Jamshedpur Hospital, a 150-bed facility, by Q4 FY27. The project carries a capital expenditure of approximately INR 70 lakhs per bed. The company anticipates the Jamshedpur unit to follow a ramp-up trend similar to that of the Raipur Hospital.

GPT Healthcare Limited has announced that it participated in a conference call with investors on Tuesday, May 19, 2026, to discuss its audited financial results for the fourth quarter and financial year ended March 31, 2026. The call was held in compliance with Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that no unpublished price sensitive information was shared during the meeting. An audio recording of the discussion has been made available on the company's website.

Financial Performance Recap

The company had previously announced its financial results for the full year FY26. For the year ended March 31, 2026, GPT Healthcare reported a total income of ₹478.5 Cr, compared to ₹415.6 Cr in the previous year. Profit after tax (PAT) for the year stood at ₹42.2 Cr, a decrease of 15.43% from ₹49.9 Cr in FY25. Revenue from operations grew by 15.14% year-on-year to reach ₹478.5 Cr.

In the fourth quarter of FY26, revenue increased to ₹128.0 Cr from ₹103.0 Cr in the same period last year, representing a growth of 24.30%. Q4 net profit came in at ₹14.7 Cr versus ₹12.9 Cr year-on-year. The table below summarises the key financial metrics for the full year:

Operational Highlights

Operationally, the company maintained an ARPOB of INR 39,243 and recorded occupancy rates of 55.90%, excluding the newly commenced Raipur facility. Including the Raipur facility, the overall occupancy stood at 45.87%. The Raipur Hospital successfully commenced operations during the year. Additionally, the company launched Respiratory ICU and cardiac care services at ILS Dum Dum and installed robotic surgical technology in Salt Lake and Howrah Hospital, with over 800 robotic surgeries performed in Salt Lake. A Memorandum of Understanding (MoU) was also signed for a 150-bed facility in Jamshedpur, targeted for commissioning by the end of FY27.

Corporate Actions

The Board of Directors has recommended a final dividend of ₹1.50 per share for FY26, subject to shareholder approval. This includes an interim dividend of ₹1.00 per share already paid, bringing the total dividend for the year to ₹2.50 per equity share. The record date for determining dividend entitlement has been fixed as July 30, 2026. The 37th Annual General Meeting (AGM) is scheduled for August 6, 2026, via video conferencing.